Birzeit Pharmaceuticals (BPC), a prominent entity listed on the Palestine Exchange (PEX), experienced a minor move in its stock performance as of the report dated November 19, 2026. The company's stock price closed at $3.90, slightly down from the previous closing price of $3.91. This represents a change of 0.26%, classified as a minor move.
Throughout the trading session, the stock's high price reached $3.90, while the low price was recorded at $3.83. The best bid volume was noted at 200 with a best bid price of $3.79, whereas the best ask price stood at $3.89 with a best ask volume of 500.
According to information available from the Palestine Exchange (PEX), Birzeit Pharmaceuticals reported a trading volume of 1,022 shares, culminating in a total value of $3,968.80. The number of trades executed was three.
Notably, the 52-week range for the stock shows a high of $4.45 and a low of $3.55. The company maintains a Price-to-Earnings (PE) ratio of 13.63, with a market capitalization valued at approximately $151.18 million. The stock remains in active status within the designated market category.
This snapshot of Birzeit Pharmaceuticals' performance reflects the nuanced movements within the PEX, indicative of broader market dynamics and investor sentiment.